Weitz & Luxenberg
| Company type | Private |
|---|---|
| Industry | Legal services |
| Founded | 1986 |
| Founder | Perry Weitz, Arthur Luxenberg |
| Headquarters | New York City , United States |
Area served | United States (New York, New Jersey, California, Michigan) |
Key people | Perry Weitz (Co-founder), Arthur Luxenberg (Co-founder), Robin Greenwald, Ellen Relkin |
| Products | Legal services (mass tort litigation including asbestos, pharmaceutical and medical device litigation, environmental litigation, defective products and consumer protection) |
Weitz & Luxenberg is a plaintiffs' legal practice based in New York City, with additional branches located in New Jersey, California, and Michigan. The firm concentrates on mass tort cases, including asbestos exposure, defective products, pharmaceutical litigation, environmental issues, and consumer protection matters.
History
Established in 1986 by lawyers Perry Weitz and Arthur Luxenberg, the firm initially gained prominence through asbestos-related lawsuits, notably achieving one of the largest asbestos verdicts in 1991 for workers at the Brooklyn Navy Yard.
In 2025, Weitz & Luxenberg secured a $117 million jury verdict for a World Trade Center steelworker exposed to asbestos, representing one of the highest individual asbestos awards in New York history.
Since then, the firm has broadened its scope to include pharmaceutical and medical device litigation, defective consumer product claims, and significant environmental contamination cases. It serves clients across the country and has obtained numerous substantial verdicts and settlements.
Practice areas
The firm focuses on complex, large-scale litigation aimed at holding corporations accountable. Its primary areas of expertise include:
- Asbestos and mesothelioma litigation: Advocating for individuals exposed to asbestos with a track record of achieving major verdicts and settlements related to mesothelioma and associated illnesses.
- Pharmaceutical and medical device litigation: Managing multidistrict litigation involving pharmaceuticals and devices such as hip replacements and transvaginal mesh implants.
- Environmental litigation: Representing communities affected by water pollution and toxic chemical releases, including cases involving MTBE contamination and Flint, Michigan.
- Defective products and consumer protection: Litigating claims related to unsafe or faulty consumer goods.
Notable cases
- An early 1990s $75 million asbestos verdict.
- A $190 million consolidated asbestos judgment in New York from 2013.
- Participation in a $2.5 billion settlement concerning defective DePuy hip implants.
- Representation in environmental contamination lawsuits resulting in water pollution settlements in Hoosick Falls, New York, and Flint, Michigan.
- A $38 million asbestos lung cancer verdict awarded in 2023, which included punitive damages.
- A $27 million PFAS contamination settlement with DuPont in New York.
Recognition
The firm and its attorneys have been acknowledged in publications such as Best Lawyers in America, Super Lawyers, and the National Law Journal's Top Verdicts Hall of Fame.
In 2023, attorney Robin Greenwald was inducted into the Trial Lawyer Hall of Fame for her work in environmental law.
Arthur Luxenberg, co-founding managing partner, earned the title of Lawyer of the Year in 2013 for mass tort litigation in New York City from Best Lawyers.
In 2025, Ellen Relkin received the Lifetime Achievement Award from the American Association for Justice for her leadership in mass torts and multidistrict litigation.
Co-founder Perry Weitz was recognized by New York Magazine for his significant contributions to mass tort law.